Utilization of biomarkers for the prognostic prediction of cardiac arrest survivors using a multi-modal approach

查看全文 作　　者：Changshin [1,2]Kang;Yeonho [1,2]You;Jung Soo [1,2]Park;Byeong Kwon [2]Park;Jae Kwang [3]Lee;Byung Kook [4]Lee 机构地区：[1]Department of Emergency Medicine,College of Medicine,Chungnam National University,Daejeon 35015,Republic of Korea;[2]Department of Emergency Medicine,Chungnam National University Hospital,Daejoen 35015,Republic of Korea;[3]Department of Emergency Medicine,Konyang University Hospital,College of Medicine,Daejeon 35015,Republic of Korea;[4]Department of Emergency Medicine,Chonnam National University Medical School,Chonnam National University Hospital,Gwangju 61469,Republic of Korea 出　　处：《World Journal of Emergency Medicine》索引2024年第15卷第2期,共4页 基　　金：supported by the research fund of Chungnam National University in 2022。 摘　　要：International guidelines for post-cardiac arrest care recommend using multi-modal strategies to avoid the withdrawal of life-sustaining therapy(WLST)in patients with the potential for neurological recovery.[1]However,a clear methodology for multi-modal approaches has yet to be developed.Neuron-specific enolase(NSE)is currently the only recommended biomarker,and the European Resuscitation Council(ERC)and the European SocietyofIntensiveCareMedicine(ESICM)have proposed a cutoff value of 60μg/L at 48 and/or 72 h after the return of spontaneous circulation(ROSC)as a multimodal prognostic tool for predicting poor neurological outcomes. 关 键 词：CARDIAC MODAL RETURN